baber/WOPTO huggingface dataset:
Patent EP-0817798-A1 (EP)
Title: Sequences nucleotidiques et proteiques de genes lats et procedes les utilisant
Inventor: XU TIAN
IPC: C07K14/47
Filed: 1996-03-26
Abstract: L'invention porte sur un gène suppresseur de tumeurs appelé suppresseur de grosses tumeurs (lats) et des procédés d'identification de gènes suppresseurs de tumeurs. Le procédé permet de produire des séquences nucléotidiques de gènes lats et les séquences d'acides aminés de leurs protéines codées ainsi que leurs dérivés (par exemple des fragments) et analogues. Dans un mode de réalisation spécifique la protéine de lats est une protéine humaine. L'invention porte en outre sur des fragments de lats (et leurs dérivés et analogues) comportant un ou plusieurs domaines d'une protéine de lats et sur des anticorps antilats et leurs dérivés et analogues, sur des procédés d'obtention de protéine de lats et leurs dérivés et analogues, notamment par recombinaison. L'invention concerne également des méthodes thérapeutiques et diagnostiques et des compositions pharmaceutiques; des plantes et animaux de recombinaison, et des procédés d'accélération de la croissance de plantes comestibles et d'animaux. Des exemples particuliers portent sur des gènes de lats isolés chez le drosophile, la souris et l'homme, et leurs séquences.
Patent EP-0833618-A1 (EP)
Inventor: CONTE UBALDO
IPC: A61K9/48
Filed: 1996-06-05
Abstract: By combining the same active ingredient in a form which is readily soluble in water or aqueous liquids and in a delayed and programmable release form in the same solid pharmaceutical form for oral administration, preferably in the form of a double-layered tablet, high plasma levels are obtained immediately after administration which lead to a consequently rapid therapeutic effect and the maintenance of high plasma levels over a prolonged period after administration. The two forms of active ingredient are accompanied by suitable adjuvants and excipients which are capable of causing the rapid disintegration of the layer containing the active ingredient in a readily soluble form and the delayed release of the active ingredient in the delayed release form.
Patent EP-0834216-A1 (EP)
Inventor: DE LEDINGHEN EDOUARD
IPC: H03D3/00
Filed: 1996-06-19
Abstract: L'invention concerne un dispositif de démodulation simultanée d'un signal multifréquentiel comprenant un processeur (27) dans lequel la démodulation est faite par le calcul. Application à la mesure par courants de Foucault.
Patent EP-0781714-A1 (EP)
Inventor: OHNISHI HIROSHI
IPC: B65D90/02
Filed: 1996-07-12
Abstract: A cargo container in which at least two panels adjacent to each other are each constituted by an integrally formed FRP sheet, and a cargo container in which a main rigidity maintaining member is constituted by a sandwich panel including a core and an FRP made skin sheet and at least two panels adjacent to each other are formed integrally. The cargo container of the present invention is light and has sufficient strength and rigidity when compared to a conventional aluminum-alloy container, and can reduce time and cost required for fabrication and production thereof. In addition, the cargo container constituted by the sandwich panel including the core and FRP made skin sheet has superior freezing refrigerating, cold insulating and heat insulating performances.
Patent EP-0837755-A1 (EP)
Title: Embout de tournevis
Inventor: BUSCH GUENTHER
IPC: B25B15/00
Filed: 1996-07-15
Abstract: Afin d'éviter l'effet de "rejet" lorsque l'on tourne des vis à l'aide d'un tournevis actionné par moteur, l'invention propose de raccourcir les bords extérieurs (5) des branches (3) d'un embout de tournevis de telle façon que les bords extérieurs viennent reposer sur ou au-dessous du côté supérieur (12) de la tête (8) de la vis.
Patent EP-0839036-A1 (EP)
Inventor: SARTANI ABRAHAM
IPC: A61K31/4422
Filed: 1996-06-28
Abstract: 1,4-Dihydropyridines have been found to counter several processes which play a role in the development of atherosclerotic vascular lesions, such as myocytes proliferation and migration, cholesterol metabolism in macrophages and oxidative modification of low density lipoproteins. They are therefore useful in the manufacture of medicaments for preventing, arresting and reversing atherosclerotic degradation in the arterial walls of humans. The preferred 1,4-dihydropyridines for this purpose are lercanidipine, (S)-lercanidipine and (R)-lercanidipine.
Patent EP-0792376-A1 (EP)
Inventor: LORINCZ ATTILA T
IPC: C12Q1/68
Filed: 1996-09-13
Abstract: L'invention concerne une réaction d'amplification continue permettant d'amplifier un acide nucléique spécifique sans qu'il soit nécessaire de répéter la réaction de manière cyclique. Le procédé permet de produire des ARN de transcription qui peuvent être détectés par différents procédés. L'invention concerne des kits d'amplification et de détection.
Patent EP-0851749-A1 (EP)
Inventor: HAMMONS JOHN LEE
IPC: A61F13/42
Filed: 1996-09-13
Abstract: L'invention concerne un article absorbant (par exemple, serviette hygiénique) comprenant une feuille supérieure, une feuille arrière et une partie centrale absorbante. Cette dernière comprend une partie de réception, une partie de stockage/répartition et une partie indicatrice. L'article absorbant présente une zone médiane orientée longitudinalement, définie par la partie de stockage/répartition, et une paire de zones latérales orientées longitudinalement située latéralement à l'extérieur de la zone médiane. La partie de réception est disposée sur la partie de stockage/répartition, et la partie indicatrice est placée, au moins en partie, dans les zones latérales. La partie de stockage/répartition a un effet d'aspiration par capillarité supérieur à celui de la partie de réception, de sorte que les liquides organiques absorbés sont aspirés depuis la partie de réception dans la partie de stockage/répartition, préservant ainsi la propreté d'aspect. L'effet d'aspiration par capillarité de la partie de stockage/répartition est également supérieur à celui de la partie indicatrice, si bien que cette dernière n'est pas maculée de manière notable tant que la capacité d'absorption de la partie de stockage/répartition n'est pas sensiblement épuisée. Ainsi, on sait que le moment est venu de changer l'article lorsque ce maculage devient apparent.
Patent EP-0818719-A1 (EP)
Inventor: KAWAHARA HISASHI
IPC: G04G13/02
Filed: 1996-11-07
Abstract: A heavy-load driving device for a electronic watch is provided that
assures reliable timekeeping operation and enables proper drive in accordance
with the power supply voltage level. When drive command circuit generates an
alarm-coincidence signal Sa, this signal Sa causes a preparatory judging
circuit 10 to operate, so as to make a judgment, in accordance with the reduced
power supply voltage level under a given load condition, as to whether or not to
allow drive of a beeper device 31, a drive-enabling signal Svm being output if
the judgment is to allow drive. By doing this, a heavy-load voltage detection
circuit 21 starts to output a drive-time judgment signal Pvh which indicates the
power supply voltage level judgment results. By means of the Svm signal, the a
drive-signal control circuit 23 begins to operate, and at a drive condition
selection circuit 25, in accordance with the signal Pvh, successive selection is
made of a drive signal to be supplied to the beeper device 31 from the
plurality of drive signals B75, B50, and B25 which are generated by the a drive-signal
generating circuit 16, the selected drive signal driving the beeper
device 31.
Patent EP-0861329-A1 (EP)
Inventor: CHROBOCZEK JADWIGA
IPC: A61K31/00
Filed: 1996-11-13
Abstract: A native or recombinant adenoviral protein complex, a pharmaceutical composition containing said protein complex, and the uses thereof for treating and preventing human and animal diseases, are disclosed. Said adenoviral protein complex consists of either 12 pentons each including at least one fibre and a penton base but no other element from an adenovirus genome, said fibre(s) and said penton base being derived from one or more adenoviruses, said pentons being bound by the penton bases and forming a proteolytic enzyme-stable dodecahedral structure, said complex having a molecular weight between 4.8 x 10<6> and 6.6 x 10<6>, and such complexes being known as dodecahedron-penton complexes; or 12 penton bases but no other element from an adenovirus genome, said penton bases being derived from one or more adenoviruses and forming a proteolytic enzyme-stable dodecahedral structure, said complex having a molecular weight between 3.2 x 10<6> and 4 x 10<6>, and such complexes being known as dodecahedron-base complexes.
Patent EP-0878379-A1 (EP)
Inventor: MORI TAKEO
IPC: B62D21/15
Filed: 1996-11-29
Abstract: A front structure of a car body, for absorbing an impact force
exerted on a front side member efficiently by intended deformation of
reinforcements. A part of an impact force exerted on a front side
member (12) is borne by the support forces of a dash cross member
(20) and a pillar brace (22) in their axial directions. A recess (24) is
provided in the dash cross member (20) at a connection of the dash
cross member (20) and the front side member (12), and a recess (26) is
provided in the pillar brace (22) at a connection of the pillar brace (22)
and the front side member (12). The dash cross member (20) and the
pillar brace (22) undergo compression deformation in the axial
directions thereof which starts at the recesses (24, 26), thereby
absorbing the impact force exerted on the front side member (12) from
the front of the car body.
Patent EP-0873335-A1 (EP)
Title: HETEROCYCLYLKONDENSIERTE BENZOYLGUANIDINE, DEREN HERSTELLUNG UND DEREN VERWENDUNG ALS INHIBITOREN DES ZELLULÄREN Na+/H+-ANTIPORTERS
Inventor: BAUMGARTH MANFRED
IPC: C07D327/06
Filed: 1996-12-16
Abstract: Cyclische Sulfone der Formel (I), worin R?1 und R2¿ jeweils unabhängig voneinander H, A, CF¿3?, CH2F, CHF2, C2F5, Hal, OH, OA, NH2, NHA, NA2, NO2 oder CN, X CR?4R5¿, C=Z, O, S, NH, NA oder NR?3, Y CR6R7¿, C=Z, O, NH, NA oder NR3, Z O, S, NH, NA, NOH, NOA, CH¿2?, CHA oder CA2, R?4, R5, R6 und R7¿ jeweils unabhängig voneinander H, A, R3, Hal, OH, OA, SH, SA, NH¿2?, NHA oder NA2 oder aber R?5 und R6 oder R7 und R8¿ jeweils zusammen auch eine Bindung, wobei in jedem Molekül maximal nur eine derartige Bindung auftreten kann, R?4 und R5¿ zusammen auch O-(CH¿2?)2-O oder O-(CH2)3-O, R?8 und R9¿ jeweils unabhängig voneinander H oder A, A Alkyl mit 1 bis 6 C-Atomen, Hal F, Cl, Br oder I und R3 unsubstituiertes oder ein-, zwei- oder dreifach durch A, OA, NH¿2?, NHA, NA2, F, Cl, Br und/oder CF3 substituiertes Phenyl oder Benzyl und n 0 oder 1 bedeuten, sowie deren physiologisch unbedenkliche Salze, zeigen antiarrhythmische Eigenschaften und wirken als Inhibitoren des zellulären Na+/H+-Antiporters.
Patent EP-0863762-A1 (EP)
Title: Procede de production et d'utilisation de preparations liquides de proteines du plasma
Inventor: MIEKKA SHIRLEY I
IPC: A61K35/16
Filed: 1996-12-02
Abstract: L'invention porte sur l'élaboration et l'utilisation de préparations liquides de protéines du plasma et en particulier de facteurs sanguins de coagulation. Elle porte plus spécifiquement, sur des préparations liquides stables de facteurs VIII et IX s'administrant par injection ou infusion pour maintenir un niveau constant de facteur de coagulation dans le sang.
Patent EP-0865619-A1 (EP)
Inventor: BERKEY GEORGE E
IPC: G02B6/287
Filed: 1996-11-26
Abstract: On réalise un coupleur pour fibres optiques, formant une gaine, en insérant des portions dénudées d'une pluralité de fibres optiques dans le trou traversant (14) d'un tube en verre, en provoquant l'affaissement de la région médiane (15) de ce tube sur les fibres et en étirant la portion centrale de la région médiane du tube. Le procédé fait appel à un tube en verre (10) dont le trou traversant comprend une portion circulaire et un creux. Plusieurs fibres optiques (21, 22) sont insérées successivement dans le tube par glissement de l'extrémité gainée dans la portion centrale du trou traversant jusqu'à ce que la portion dénudée (23, 24) de la fibre soit centrée dans le tube. La portion dénudée de la fibre est ensuite transférée latéralement dans le creux du trou traversant (14). Après avoir introduit toutes les fibres dans la portion circulaire du trou traversant et les avoir transférées vers le creux, une fibre de remplissage (28) est insérée dans la portion circulaire du trou traversant. Le coupleur résultant présente une perte d'excédent faible.
Patent EP-0790125-A1 (EP)
Inventor: GEIS ANDRE
IPC: B41F35/00
Filed: 1997-01-31
Abstract: The cleaning device cleans the surfaces of cylinders (1). A cleaning cloth (4) extends over the length of the cylinder. A pressing element acts on the cloth to press it to the cylinder. The pressing element consists of an elastically deformable hollow body (5). When internal pressure is applied to the hollow body, it expands elastically, increasing the spacing towards the cylinder surface. Air is supplied to the hollow body via a two-way valve (8). The two-way valve can be switched from excess pressure to negative pressure, so that the hollow body can pass from an outward position via a neutral rest position to a position stretched inwards.
Patent EP-0808817-A1 (EP)
Inventor: PELSTER THOMAS DR
IPC: B01J27/06
Filed: 1997-05-12
Abstract: Preparation of halogenated phthalic acids (or derivatives) (I) involves reacting optionally substituted phthalic acids (or derivatives) (II) with a halogenation agent in fuming sulphuric acid in the presence of a compound containing iodine as catalyst. The novelty is that halogenation is carried out at 100-160 degrees C.
Patent EP-0813108-A1 (EP)
Inventor: FRANK LEE F
IPC: G03C1/74
Filed: 1997-06-02
Abstract: A vapor deposition method and apparatus that performs the method. In the method, a supply of vaporizable material is maintained, in a first zone, in thermal and phase equilibrium with a saturated vapor at a first temperature. A volume of the vapor is withdrawn to a second zone. The temperature of the volume of vapor in the second zone is adjusted to a second temperature in excess of the first temperature. The volume of vapor is delivered to a third zone. A substrate is transported through the third zone. The substrate has a third temperature below the first temperature. During the transporting, a portion of the volume of vapor is condensed onto the substrate to provide a condensate. During the condensing, the temperature of the substrate is raised to substantially the first temperarature.
Patent EP-0816320-A1 (EP)
Inventor: REGNAT DIETER DR
IPC: C07C43/164
Filed: 1997-06-18
Abstract: 2,2'-Biaryl-bisethers (I) of formula (A; A = -O-(CH2)n-R) are new; in which R<1>, R<2>, R<3> = hydrogen (H), alkyl or alkoxy with 1-4 carbon (C) atoms or 2-4 C alkenyl; or CR<1>-CR<2> = a 6 C ring; m, n = 0 or 1; (m+n) = 1 or 2; R = a phenyl or naphthyl group, optionally substituted by 1-4 C alkyl, amino or a dialkylamino group with a total of 2-8 C.
Patent EP-0823213-A1 (EP)
Inventor: TANAKA YASUYORI
IPC: A01N25/06
Filed: 1997-08-07
Abstract: The present invention relates to an insecticidal
composition comprising (a) 0.1-10% by weight of
2,4-dioxo-1-(2-propynyl)-imidazolidin-3-yl methyl chrysanthemate,
(b) 2.5-50% by weight of a fatty acid ester of
16-19 carbon atoms, (c) 2.5-30% by weight of a sorbitan
fatty acid ester, (d) 0.5-1% by weight of at least one
alcohol selected from the group consisting of ethanol,
1-propanol, 2-propanol, ethylene glycol, diethylene
glycol, triethylene glycol, propylene glycol, dipropylene
glycol, butylene glycol and glycerin and (e) 40-93.5%
by weight of a saturated hydrocarbon of 8-18
carbon atoms; an insecticidal aerosol composition
comprising 5-30% by weight of said insecticidal
composition, 40-85% by weight of water and 10-50% by
weight of a propellant; and a method for controlling
harmful insects which comprises applying said
insecticidal aerosol composition to them.
Patent EP-0847126-A1 (EP)
Inventor: LEITENBERGER THOMAS
IPC: H02K11/02
Filed: 1997-10-04
Abstract: The motor has a commutator (13), commutator brushes (14,15) and a manually operated electrical power switch (22) for switching the motor on and off. The power switch has a switching mechanism (24) which acts upon at least one commutator brush to set the brush on the commutator when switching the motor on and removing it from the commutator when switching the motor off. The commutator brush is held in a brush holder and the switching mechanism engages the brush holder. The holder has at least one two-armed lever with one arm engaged by the switching mechanism to pivot the lever. The other arm carries the brush.
Patent EP-0839643-A1 (EP)
Inventor: RUKAVINA THOMAS G
IPC: C08J5/12
Filed: 1997-11-04
Abstract: The present invention relates to an aircraft transparency including an electroconductive metal oxide coating over a rigid plastic substrate, and a polyurethane protective liner over the metal oxide coating, and more specifically to the use of a primer for adhering the metal oxide coating to the substrate and/or a primer for adhering the polyurethane protective liner to the metal oxide coating. The metal oxide primer includes a carbonate diol-based crosslinked polyurethane. The polyurethane primer is selected from the group consisting of a crosslinked copolymer of acrylic acid and substituted acrylates such as 2-ethylhexylacrylate; a crosslinked copolymer of cyanoethylacrylate and acrylic acid; and a crosslinked terpolymer of 2-ethylhexylacrylate, cyanoethylacrylate and acrylic acid.
Patent EP-0782133-A1 (EP)
Inventor: OKA NOBUYUKI
IPC: G11B13/04
Filed: 1993-07-28
Abstract: An optical disc apparatus which records and reproduces desired information by using, for example, a magneto-optical disc and moreover reproduce a compact disc, and adjusts the focus position to the optimum position for each recording medium. For reproducing an optical disc having pits and lands, a magneto-optical disc having grooves and lands carved previously and a composite disc having a pit area and a groove area, the focus bias is switched in accordance with the type of disc or the area of disc to make the optical characteristic of each disc to be optimum, so as to provide an apparatus in which the jitter can be reduced and the error correction rate can be lowered.
Patent EP-0798057-A1 (EP)
Inventor: ARNAUTU GHEORGHE DIPL-ING
IPC: B21B19/06
Filed: 1997-03-25
Abstract: The rolling mill has at least three inclined rollers at 120 degrees to each other. Each roller has an approach part in front of the shoulder, a trailing part behind it. The continuous transitional section from approach to trailing part is determined by three tangential radii, which merge into the sections. The central transitional radius (R2) is larger than the approach radius (R1), and smaller than the trailing radius (R3). Transitional and trailing radii have the same direction of curvature, and all radii are described by the shoulder height (Hs) of the Assel roller. Shoulder height is calculated from blank diameter and the ratio of hollow block diameter and hollow block wall.
Patent EP-0795794-A1 (EP)
Inventor: IMAI MASAAKI
IPC: G03G15/00
Filed: 1997-03-12
Abstract: A device for measuring life of a process unit, the device including: a process unit detachably mountable in a main unit, the process unit including at least a photosensitive body having a surface on which can be formed a static electric latent image; a counter for measuring life of the process unit; an unused indication sheet provided internally to each unused process unit and discharged from the process unit when an unused process unit is mounted in the main unit; a sensor provided in the main unit, the sensor detecting discharge of each unused indication sheet and outputting an unused indication sheet discharge sensor signal accordingly; and a control unit provided in the main unit and capable of receiving the unused indication sheet discharge sensor signal from the sensor, the control unit resetting the counter upon receipt of the unused indication sheet discharge sensor signal from the sensor.
Patent EP-0891771-A1 (EP)
Inventor: RATH MATTHIAS
IPC: A61K31/40
Filed: 1997-07-08
Abstract: A therapeutic lysine-based composition and methods for its use in the
prevention and treatment of cardiovascular disease is disclosed. The
composition includes at least one lysine compound. The composition may also
preferentially include ascorbate, proline and vitamin D or compounds thereof.
The composition may also include N-acetyglucosamine and other compounds
restoring and maintaining optimum biological function of the vascular wall. A
patient at risk of developing or with a pre-existing cardiovascular disease is
treated by administering orally or parenterally a desired dosage of the
composition on a daily basis.
Patent EP-0844780-A1 (EP)
Inventor: GARLAND STUART MANDEL
IPC: H04M11/00
Filed: 1997-11-18
Abstract: The system of the invention consists of a central office service unit
(COSU) connected to a plurality of switching systems via dedicated telemetry trunks
or a common channel signaling network such as the CCS7 network. The switching
systems are connected to a plurality of inbound-only TIUs located on the customer
premise that are in turn connected to customer devices such as utility meters,
appliances, security systems or the like. The TIUs are inbound-only that can
originate calls but cannot answer calls initiated by the controlling entity. A
controlling entity, such as a utility, is connected to one of the switching systems over
a customer line such that the controlling entity can be connected to any TIU hosted
by the switching systems. The controlling entity requests that an alerting tone be
sent by the COSU to a desired TIU. The COSU, as is known in the art, delivers an
alert tone through a suppressed ringing connection to the TIU that does not audibly
ring the customer's telephone. The TIU does not "answer" this tone by going off
hook such that no connection is established and the telemetry call is taken down.
While the TIU does not answer the alert tone, the tone alerts the TIU to perform one
or more functions such as retrieve data from a utility meter, check the status of an
appliance or the like. As an alternative to the alert tone, a digital signal can be
transmitted to alert the TIU. After performing the desired function, the TIU is
programmed to call the controlling entity and a connection is established between
the TIU and the controlling entity. The TIU can then transmit the results of the
function to the controlling entity and the controlling entity can download further
instructions, programs or the like to the TIU.
Patent EP-0795360-A1 (EP)
Inventor: AQUILINA JEAN-PAUL
IPC: B08B17/04
Filed: 1997-03-11
Abstract: The procedure for maintaining the walls of a channel includes projecting a peal-able film on to the walls. After a certain period of use this film is then mechanically removed together with the accumulation of grease, dirt and dust and these particles are blown of the conduit. Both the application of this film, and the subsequent removal are carried out by a remotely controlled robot (1) with a microprocessor programmed to control different elements of the robot.   The microprocessor is connected to an external station for control of the robot and inspection of the channel. The robot carries lights, and a video camera system for transmission of video images from the robot back to the remote monitoring station. The rotor comprises a central body with driving wheels mounted on pivoting arms to run against the internal surfaces of the conduit.
Patent EP-0849554-A1 (EP)
Inventor: VIARD NICOLAS
IPC: A23L3/375
Filed: 1997-08-13
Abstract: Food products are treated in an installation (10) with a control unit (30) which monitors and controls the operating parameters. A number of detectors (50A-E) measure various operating parameters and relay the information to a surveillance unit (54). If the parameters are outside their normal ranges this information is displayed (54), at a point remote from the installation.